| Date Filed | Type | Description |
| 07/26/2023 |
8-K
| Quarterly results |
| 05/15/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/26/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
8-K
| Quarterly results |
| 12/08/2022 |
8-K
| Quarterly results |
| 11/01/2022 |
8-K
| Quarterly results |
| 10/27/2022 |
8-K
| Quarterly results |
| 07/28/2022 |
8-K
| Quarterly results |
| 07/21/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 04/26/2022 |
8-K
| Quarterly results |
| 01/26/2022 |
8-K
| Quarterly results |
| 10/27/2021 |
8-K
| Quarterly results |
| 07/29/2021 |
8-K
| Quarterly results |
| 07/15/2021 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 05/05/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/20/2021 |
8-K
| Quarterly results |
| 01/27/2021 |
8-K
| Quarterly results |
| 07/23/2020 |
8-K
| Quarterly results |
| 07/15/2020 |
8-K
| Quarterly results |
| 07/13/2020 |
8-K
| Quarterly results |
| 05/08/2020 |
8-K
| Quarterly results |
| 04/23/2020 |
8-K
| Quarterly results |
| 01/30/2020 |
8-K
| Quarterly results |
| 10/23/2019 |
8-K
| Quarterly results |
| 07/23/2019 |
8-K
| Quarterly results |
| 05/08/2019 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events |
| 04/23/2019 |
8-K
| Quarterly results |
| 01/31/2019 |
8-K
| Quarterly results |
| 01/15/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 10/23/2018 |
8-K
| Quarterly results |
| 07/26/2018 |
8-K
| Quarterly results |
| 06/15/2018 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 06/07/2018 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Underwriting Agreement, by and among Edwards Lifesciences Corporation and Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC, for themselves and as representatives of the several underwriters listed in Schedule A therein",
"Underwriting Agreement, by and among Edwards Lifesciences Corporation and Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC, for themselves and as representatives of the several underwriters listed in Schedule A therein",
"Computation of Ratio of Earnings to Fixed Charges" |
|
|